In the second episode of The Deep End, listeners hear what it’s like to live with severe depression and the backstory of an experimental treatment.
After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...
A recent case report published in the Journal of Psychoactive Drugs tells the story of a middle-aged man who underwent an ...
B-2D, a brain receptor targeted by ketamine. Using cryo-EM, they visualize how ketamine binds to the receptor, controlling its ion channel activity.